Company · CIK 1567264
INTENSITY THERAPEUTICS, INC.
| CIK | 1567264 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CT |
| Listed | INTS (Nasdaq) |
| First annual or quarterly report | 2023-08-14 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-280681 | 2024-07-03 | 2026-03-23 | 11 | |
| 333-286683 | 2025-04-22 | 2025-04-25 | 4 | |
| 333-283797 | 2024-12-13 | 2024-12-19 | 2 | |
| 333-280684 | 2024-07-03 | 2024-07-11 | 2 | |
| 333-260565 | 2021-10-28 | 2023-06-30 | 19 |
Filings
40| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-23 | 424B5Shelf takedown | 333-280681 | 0001567264-26-000020 |
| 2025-12-04 | 424B5Shelf takedown | 333-280681 | 0001567264-25-000108 |
| 2025-11-03 | 424B5Shelf takedown | 333-280681 | 0001628280-25-047924 |
| 2025-06-18 | 424B5Shelf takedown | 333-280681 | 0001628280-25-032094 |
| 2025-06-12 | 424B5Shelf takedown | 333-280681 | 0001628280-25-031040 |
| 2025-06-11 | 424B5Shelf takedown | 333-280681 | 0001628280-25-030704 |
| 2025-06-11 | 424B5Shelf takedown | 333-280681 | 0001628280-25-030702 |
| 2025-04-25 | 424B4Final prospectus | 333-286683 | 0001628280-25-020056 |
| 2025-04-24 | EFFECTDeclared effective | 333-286683 | 9999999995-25-001244 |
| 2025-04-24 | S-1/AAmendment | 333-286683 | 0001628280-25-019491 |
| 2025-04-22 | S-1Registration filed | 333-286683 | 0001628280-25-018892 |
| 2025-03-28 | DRSDraft made public | 377-07829 | 0001628279-25-000170 |
| 2024-12-19 | EFFECTDeclared effective | 333-283797 | 9999999995-24-003845 |
| 2024-12-13 | S-1Registration filed | 333-283797 | 0001628280-24-051180 |
| 2024-11-22 | 424B5Shelf takedown | 333-280681 | 0001628280-24-048908 |
| 2024-11-20 | 424B5Shelf takedown | 333-280681 | 0001628280-24-048703 |
| 2024-07-11 | EFFECTDeclared effective | 333-280684 | 9999999995-24-002135 |
| 2024-07-11 | EFFECTDeclared effective | 333-280681 | 9999999995-24-002134 |
| 2024-07-03 | S-3Shelf registered | 333-280684 | 0001628280-24-031100 |
| 2024-07-03 | S-3Shelf registered | 333-280681 | 0001628280-24-031093 |
| 2023-06-30 | 424B4Final prospectus | 333-260565 | 0001213900-23-053470 |
| 2023-06-29 | EFFECTDeclared effective | 333-260565 | 9999999995-23-001911 |
| 2023-06-29 | S-1/AAmendment | 333-260565 | 0001213900-23-052684 |
| 2023-06-23 | S-1/AAmendment | 333-260565 | 0001213900-23-051151 |
| 2023-06-09 | S-1/AAmendment | 333-260565 | 0001213900-23-047788 |
| 2023-05-18 | S-1/AAmendment | 333-260565 | 0001213900-23-041113 |
| 2023-01-27 | S-1/AAmendment | 333-260565 | 0001213900-23-005668 |
| 2023-01-13 | S-1/AAmendment | 333-260565 | 0001213900-23-002717 |
| 2022-11-02 | S-1/AAmendment | 333-260565 | 0001213900-22-068432 |
| 2022-10-03 | S-1/AAmendment | 333-260565 | 0001213900-22-061060 |
| 2022-09-20 | S-1/AAmendment | 333-260565 | 0001213900-22-057124 |
| 2022-05-16 | S-1/AAmendment | 333-260565 | 0001213900-22-027136 |
| 2022-04-20 | S-1/AAmendment | 333-260565 | 0001213900-22-020664 |
| 2022-01-07 | S-1/AAmendment | 333-260565 | 0001213900-22-001099 |
| 2021-12-09 | S-1/AAmendment | 333-260565 | 0001213900-21-064375 |
| 2021-12-08 | S-1/AAmendment | 333-260565 | 0001213900-21-064145 |
| 2021-11-18 | S-1/AAmendment | 333-260565 | 0001213900-21-060634 |
| 2021-11-12 | S-1/AAmendment | 333-260565 | 0001213900-21-058814 |
| 2021-10-28 | S-1Registration filed | 333-260565 | 0001213900-21-055138 |
| 2021-09-20 | DRSDraft made public | 377-05513 | 0001213900-21-048854 |